Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amoxicillin + clavulanic acid (Avogadro Lifesciences)
- Development stage
- Unknown
- Lead developer
- Avogadro Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Hardclav DDS is a branded generic combination antibiotic containing amoxicillin, a penicillin-class beta-lactam antibiotic, and clavulanic acid (as potassium clavulanate), a beta-lactamase inhibitor. Developed by Avogadro, it is used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, and skin infections. The addition of clavulanic acid protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending its spectrum of activity. The "DDS" designation typically refers to a "Dry Syrup" formulation, often in a "Double Strength" concentration for pediatric use.
- Brand names
- Hardclav DDS
- Other names
- Co-amoxiclavAmoxicillin/Clavulanate
02
Targets
β-lactamasePBP (Penicillin-binding protein family)PBP3 (Penicillin-binding protein 3)
Beyond the preview
Go deeper on amoxicillin + clavulanic acid (Avogadro Lifesciences).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on amoxicillin + clavulanic acid (Avogadro Lifesciences).